Recommended Free CME and Other Educational Activities


Recommended Free CME and Other Educational Activities

Play all audios:


Recommended Free CME and Other Educational ActivitiesOptimizing the Use of Disease-Modifying Therapies Across the Spinal Muscular Atrophy Care Continuum: An Expert TheraTalkDisease-modifying


therapies (DMTs) have transformed the treatment of spinal muscular atrophy (SMA). However, optimizing their use in clinical practice, including across diverse ages and stages of disease


progression, can be complex. How confident are you in integrating these therapies effectively into your practice? …Free Live Webinar1.0 CME/CEJun 10, 2025AccessInnovating Cancer Care: The


Emerging Role of Subcutaneous ICI TherapyJoin us for an expert-led webinar designed to equip oncology care teams with the latest evidence and strategies for integrating subcutaneous (SC)


immune checkpoint inhibitors (ICI) into practice. This interactive session will compare intravenous (IV) versus SC ICI administration, empowering you to make informed, patient-centered…Free


Live Webinar0.5 CME/CEJun 12, 2025AccessEvidence-Based Multidisciplinary Management of Hepatocellular Carcinoma in the Context of CirrhosisJoin us for a dynamic live webinar designed to


tackle critical clinical gaps in hepatocellular carcinoma (HCC) and cirrhosis management, featuring real-world data from a quality improvement initiative. …Free Live Webinar0.5 CME/CEJun 25,


2025AccessOptimizing Care Coordination for Seamless Integration of CAR T-Cell Therapy in Earlier Lines of MM TreatmentJoin us for a live webinar where leading experts in CAR T-cell therapy


and multiple myeloma (MM) will discuss solutions for overcoming persistent gaps in CAR T-cell care coordination. Leveraging key insights stemming from a review of complex clinical cases in


recent provider clinical practicums sessions, expert faculty will present the…Free Live Webinar0.75 CME/CEJun 18, 2025AccessMechanisms in Medicine: Preparing for a Paradigm Shift in


Myelofibrosis TreatmentThe treatment landscape for myelofibrosis (MF) continues to evolve, with several novel therapies in clinical trials displaying disease-modifying potential to alter the


underlying disease biology of MF and thereby prolong survival. …Free Live Webinar0.5 CME/CEJul 1, 2025AccessMultiple Sclerosis in Focus: Expert Approaches to Detecting Disease Progression,


Treatment Selection, and Patient-Centered CareRecent understanding of multiple sclerosis (MS) has increasingly emphasized the impact of silent progression on disability accumulation and


long-term outcomes. Detecting and monitoring patients for subtle changes, particularly those related to progression independent of relapse activity (PIRA), is clinically challenging. …Free


Live Webinar1.0 CME/CEJul 10, 2025AccessMaximizing Second Chances: Effective Strategies for Preventing Recurrent Myocardial InfarctionRecurrent myocardial infarctions (RMIs) frequently occur


within the first year after an initial MI, contributing to significant morbidity, mortality, and healthcare strain. Persistent challenges include underuse of preventive measu


res and delays in treatment. With over 25% of MI-related deaths occurring before hospital admission, timely…Free Live Webinar1.0 CME/CEMOCJun 25, 2025AccessA Comprehensive Exploration of


Immunotherapy-Based Insights in the Management of Advanced/Metastatic Nasopharyngeal CarcinomaAre you up to date on the newest treatment strategies in nasopharyngeal carcinoma (NPC)? Test


your skills and expand your confidence to integrate immunotherapy into the management of patients with NPC. Receive real-time feedback and curated resources based on your current level of


knowledge. …Free AdaptiveMedEd0.25 CME/CEAccessOvercoming Barriers to Optimal Treatment and Management of FLT3-Mutated AML in the Frontline SettingAre you up to date on the latest evidence


in FLT3-mutated AML? Challenge yourself with this AdaptiveMedEd activity exploring cutting-edge evidence on new developments in the management of FLT3-mutated AML. …Free AdaptiveMedEd0.25


CME/CEAccessNavigating HIV Prevention: From Guidelines to Clinical PracticeImplementing the latest evidence and updated guidelines on pre-exposure prophylaxis (PrEP) is crucial for effective


HIV prevention and delivery of PrEP services. …Free Online Activity1.0 CME/CEAccessPersonalizing Evidence-Based Care for Women Living With HIV During PregnancyAdvances in antiretroviral


therapy (ART) have made it safer than ever for women living with HIV to become pregnant and give birth, but providers are challenged to navigate a growing therapeutic landscape and shifting


guidelines to provide personalized and evidence-based care during this phase of life. In this Clinical Case Challenge,…Free Clinical Case Study0.25 CME/CEMOCAccessOptimizing Strategies to


Avoid Drug-Drug Interactions for Cisgender Women Living With HIVWhile the safety and tolerability of antiretroviral agents (ARVs) has increased substantially since the early days of the HIV


epidemic, many ARVs have the potential to interact with other medications, including some commonly prescribed for cisgender women living with HIV throughout their lifetime. …Free Clinical


Case Study0.25 CME/CEMOCAccessSupporting Safe Conception and Pregnancy for Women Living With HIVTremendous evidence is now available to support the efficacy of antiretroviral therapy (ART)


to maintain viral suppression and prevent HIV transmission during conception, pregnancy, and childbirth. Providers must be knowledgeable of the latest guidelines and clinical evidence to


ensure appropriate ART prescribing and supportive…Free Online Activity0.5 CME/CEMOCAccessHonoring Her Choice: Counseling Women Living With HIV About Infant FeedingThe topic of infant feeding


in the context of HIV has long been controversial and confusing due to a lack of clear guidance, especially in high-income countries. However, increasing data suggest that the chances of


HIV transmission through breast or chestfeeding are minimal when the parent has an undetectable viral load. Given the…Free Online Activity0.25 CME/CEMOCAccessMinimizing Dru


g-Drug Interactions for Cisgender Women Living With HIVIn addition to their high efficacy and tolerability, many contemporary antiretroviral agents (ARVs) are associated with fewer drug-drug


interactions (DDIs) than earlier ARVs. However, some ARVs still have the potential to interact with medications commonly prescribed for cisgender women living with HIV. …Free Online


Activity0.25 CME/CEMOCAccessNavigating the Heat: Prioritizing the Needs of Women Living With HIV During Perimenopause and MenopauseChanges associated with menopause often cause symptoms that


significantly impact women's physical and psychological wellbeing, and these changes may occur earlier and cause more severe symptoms for women living with HIV. While the topic of menopause


and HIV has long been understudied, new data and guidelines are emerging to inform care…Free Online Activity0.25 CME/CEMOCAccessThe Whole in Holistic: Empowering Women Living With HIV to Be


Advocates in Their CareWellness for women living with HIV depends on many factors beyond just viral load and CD4 count, but topics such as sexual and mental health can be uncomfortable to


bring up during appointments. Creating a safe, supportive environment where women feel empowered to speak up about their holistic health needs is essential to ensure women…Free Online


Activity0.25 CME/CEMOCAccessClinical Mic Drop: Expert Perspectives on the Latest Evidence Supporting Care for Women Living With HIVAs women continue to be better represented in HIV clinical


studies, it is more important now than ever to stay up to date on the latest evidence impacting their care. …Free Online Activity0.25 CME/CEMOCAccessInnovations in Targeted Therapies:


Redefining Care for Advanced/Metastatic Lung Cancer PatientsIn the fourth webcast in the Hot Topics in Lung Cancer series, learn more about the latest advances in targeted therapies for


advanced and metastatic NSCLC. Join expert faculty as they review current and emerging treatments for key oncogenic drivers, including KRAS, MET, RET, ALK, and HER2. …Free Online Activity1.5


CME/CEAccessNavigating Advances in Cystic Fibrosis CareBreakthrough therapies have significantly improved life expectancy and quality of life for people with cystic fibrosis (CF), yet


challenges remain in navigating these breakthroughs and coordinating comprehensive care across multiple specialties. Access this video recording of a live seminar led by a renowned CF expert


to catch up on the…Free Online Activity1.0 CME/CEAccessAdvancing Frontline Care in Bladder Cancer: Personalizing Practice With the Latest EvidenceJoin our comprehensive program tailored to


provide personalized education based on your existing knowledge on the latest evidence in the frontline treatment of locally advanced or metastatic bladder cancer. …Free AdaptiveMedEd0.25


CME/CEAccess